Steward Partners Investment Advisory’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20
Closed -$98 4135
2025
Q1
$98 Hold
20
﹤0.01% 3945
2024
Q4
$167 Sell
20
-50
-71% -$437 ﹤0.01% 3909
2024
Q3
$728 Hold
70
﹤0.01% 3558
2024
Q2
$1.38K Hold
70
﹤0.01% 3348
2024
Q1
$1.79K Buy
70
+20
+40% +$513 ﹤0.01% 3310
2023
Q4
$1.38K Hold
50
﹤0.01% 3266
2023
Q3
$3.05K Hold
50
﹤0.01% 2983
2023
Q2
$3.3K Sell
50
-25
-33% -$1.83K ﹤0.01% 2923
2023
Q1
$4.78K Hold
75
﹤0.01% 2804
2022
Q4
$10.4K Hold
75
﹤0.01% 2526
2022
Q3
$10K Buy
+75
New +$8.48K ﹤0.01% 2520
2022
Q2
Hold
0
3247
2022
Q1
Hold
0
3287
2021
Q4
Sell
-125
Closed -$29.5K 3187
2021
Q3
$31K Hold
125
﹤0.01% 2112
2021
Q2
$52K Sell
125
-27
-18% -$10.7K ﹤0.01% 3278
2021
Q1
$59.4K Buy
152
+27
+22% +$13.3K ﹤0.01% 1892
2020
Q4
$70K Sell
125
-14
-10% -$8.87K ﹤0.01% 1505
2020
Q3
$97K Buy
139
+23
+20% +$17.9K ﹤0.01% 1233
2020
Q2
$92K Hold
116
﹤0.01% 1187
2020
Q1
$69K Sell
116
-14
-11% -$13.6K ﹤0.01% 1136
2019
Q4
$147K Sell
130
-6
-4% -$6.52K ﹤0.01% 979
2019
Q3
$161K Buy
136
+3
+2% +$4.58K 0.01% 912
2019
Q2
$218K Sell
133
-1
-0.7% -$1.73K 0.01% 784
2019
Q1
$272K Buy
+134
New +$236K 0.01% 665
2018
Q4
Sell
-131
Closed -$247K 924
2018
Q3
$247K Sell
131
-2
-2% -$4.13K 0.01% 672
2018
Q2
$270K Buy
133
+1
+0.8% +$2.28K 0.02% 586
2018
Q1
$293K Hold
132
0.02% 539
2017
Q4
$305K Buy
132
+117
+780% +$238K 0.02% 448
2017
Q3
$27K Hold
15
﹤0.01% 856
2017
Q2
$21K Hold
15
﹤0.01% 842
2017
Q1
$18K Hold
15
﹤0.01% 787
2016
Q4
$12K Buy
+15
New +$11.9K 0.01% 524

Other funds holding BLUE

Steward Partners Investment Advisory's BLUE Position: Q2 2025 in Review

Steward Partners Investment Advisory sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 20 shares — an estimated $98 sold.

Steward Partners Investment Advisory first reported a position in BLUE in Q4 2016 and held it in 30 quarters. The position peaked at $305K in Q4 2017. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Steward Partners Investment Advisory reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 20 bluebird bio shares in Q2 2025, an estimated $98.
  • Steward Partners Investment Advisory first reported a position in bluebird bio in Q4 2016 and held it in 30 quarters.
  • Steward Partners Investment Advisory's bluebird bio position peaked at $305K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2025, filed 12 Aug 2025.